Welcome to the e-CCO Library!

P856: Compositional changes in the gut microbiota of Korean inflammatory bowel disease patients are linked to clinical phenotypes
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

C. H. Choi*1, Y. Kim1, S. Y. Shin1, K. Kim2, K-M. Lee3, S-A. Jung4, C. Serrano5, S. C. Lee5

Created: Friday, 22 February 2019, 9:41 AM
P856: The gut microbiota composition and metabolic activity of HLA-B27 transgenic rats with gut inflammation resembles the dysbiotic characteristics of human inflammatory bowel disease
Year: 2018
Source: ECCO '18 Vienna
Authors:

V. Svolos1*, B. Nichols1, D. Bolognini2, C. Quince3, U.Z. Ijaz4, R.T. Papadopoulou1, C. Ansalone5, J. Salmond6, R. Klopfleisch7, D.R. Gaya8, R.K. Russell9, R. Hansen9, K. Gerasimidis1, S. Milling5

Created: Thursday, 21 February 2019, 9:14 AM
P857: Dysbiosis and ecotypes of the salivary microbiome associated with inflammatory bowel diseases and the assistance in diagnosis of diseases using oral bacterial profiles
Year: 2018
Source: ECCO '18 Vienna
Authors:

N. Chen1*, Z. Xun2, Q. Zhang2, F. Chen2

Created: Thursday, 21 February 2019, 9:14 AM
P857: The microbiota profile reflects disease severity in paediatric onset IBD
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

M. Malham*1, B. Lilje2, K. Winther3, G. Houen2, P. S. Andersen2, C. Jakobsen1,4

Created: Friday, 22 February 2019, 9:41 AM
P858: Crohn’s disease is characterised by a fungal dysbiosis
Year: 2018
Source: ECCO '18 Vienna
Authors:

A. Frau1*, D. Jonkers2, J. Penders2, M. Pierik2, U.Z. Ijaz3, B. Campbell1, A. Darby4, J. Kenny4, N. Hall5, C. Probert1

Created: Thursday, 21 February 2019, 9:14 AM
P858: Impact of ileocaecal resection on gut microbiota in ileal Crohn’s disease patients
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

J. Opstelten*1, F. Paganelli2, M. Bonten2, R. Willems2, B. Witteman3,4, H. Leavis5, B. Oldenburg1

Created: Friday, 22 February 2019, 9:41 AM
P858: Prevalence of sarcopenia in patients with inflammatory bowel disease and factors associated with it
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Dharap, V.(1)*;Abraham, P.(2);Desai, D.(2);Gupta, T.(2);Dhoble, P.(2);Mehta, N.(3);Modhe, J.(3);
Created: Friday, 14 July 2023, 11:12 AM
P859: Accuracy of self-reporting of immune-mediated inflammatory diseases by patients with inflammatory bowel disease. Results from a hospital-based cohort.
Year: 2023
Source: ECCO’23 Copenhagen
Authors: De Francisco Garcia, R.M.(1,2)*;Pérez-Martínez, I.(1,2);Castaño-García, A.(1);Celada-Sendino, M.(1);Fernández-González, E.(1);García-Pérez, C.(2);Martínez-Gozález, S.(2);Rolle, V.(2);Queiro, R.(3);Alonso-Castro, S.(3);Santos-Juanes, J.(4);Gueimonde, M.(2);Riestra, S.(1,2);
Created: Friday, 14 July 2023, 11:12 AM
P859: Hepatitis E seroprevalence in Portuguese inflammatory bowel disease patients under immunosuppression is higher than expected
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

M. Garrido*1, T. Guedes1, M. Abreu2, I. Pedroto1, P. Lago1

Created: Friday, 22 February 2019, 9:41 AM
P859: The functional exoproteome as a driver and predictor of IBD status: Proteases from bacteria influence host health
Year: 2018
Source: ECCO '18 Vienna
Authors:

L.S. Osborne1*, J. Marchesi1,2

Created: Thursday, 21 February 2019, 9:14 AM
P860: Combination of prebiotic FOS and adalimumab for prevention of dysbiosis in active Crohn’s disease: A pilot study
Year: 2018
Source: ECCO '18 Vienna
Authors:

N. Borruel1*, C. Herrera-deGuise1, E. Varela1, M. Barreiro2, B. Beltran3, J.P. Gisbert4, X. Aldeguer5, J. Guardiola6, L. Menchén7, V. Robles1, F. Casellas1, F. Guarner1

Created: Thursday, 21 February 2019, 9:14 AM
P860: Evaluation of the probiotic features of two different multi-strain probiotic preparations from two different manufacturers
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

S. Colombo*1, V. Sagheddu2, M. Elli2, D. Mora3

Created: Friday, 22 February 2019, 9:41 AM
P860: The Costs of Inflammatory Bowel Diseases in High-Income Settings
Year: 2023
Source: ECCO’23 Copenhagen
Authors: BurischPhD, J.(1)*;Zhao, M.(2);Odes, S.(3);De Cruz, P.(4);Vermeire , S.(5);Bernstein, C.N.(6);Kaplan, G.G.(7);Duricova, D.(8);Greenberg, D.(9);Melberg, H.O.(10);Watanabe, M.(11);Ahn, H.S.(12);Targownik, L.(13);Pittet, V.E.H.(14);Annese, V.(15);Park, K.(16);Konstantinos H. , K.H.(17);Høivik, M.L.(18);Krznaric, Z.(19);Chaparro, M.(20);Loftus, E.V.(21);Lakatos, P.L.(22);Gisbert, J.P.(23);Bemelman, W.(24);Moum, B.(18);Gearry, R.B.(25);Kappelman, M.D.(26);Hart, A.(27);Pierik, M.(28);Andrews, J.(29);Ng, S.(30);D'Inca, R.(31);Munkholm, P.(32);
Created: Friday, 14 July 2023, 11:12 AM
P861: Differences in bacteroidal genotypes between newly diagnosed ulcerative colitis patients and healthy controls
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

I. Baston*1, R. Sueiro2, C. Calviño1, D. De la Iglesia1, R. Ferreiro-Iglesias1, J. M. Leiro2, J. E. Dominguez-Munoz1, M. Barreiro-de Acosta1

Created: Friday, 22 February 2019, 9:41 AM
P861: Frequency and Influence of a Positive Family History on the Clinical Course of Inflammatory Bowel Diseases
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Liava, C.(1)*;Sinakos, E.(1);Dimitroulas, T.(1);Navrozidou, C.(2);Akriviadis, E.(1,2);
Created: Friday, 14 July 2023, 11:12 AM
P861: Short-chain fatty acids as a marker of intestinal dysbiosis in patients with inflammatory bowel diseases
Year: 2018
Source: ECCO '18 Vienna
Authors:

N. Danilova1, S. Abdulkhakov1,2, T. Grigoryeva2*, M. Markelova2, I. Vasilyev2, S. Malanin2, A. Tyakht3,4, A. Pavlenko4, A. Odintsova5, M. Ardatskaya6, R. Abdulkhakov1

Created: Thursday, 21 February 2019, 9:14 AM
P862: Colonisation of viable bacteroidetes in fresh or frozen faecal microbiota transplantation
Year: 2018
Source: ECCO '18 Vienna
Authors:

M. Takahashi1*, D. Ishikawa1, M. Kamei1, T. Shibuya1, T. Osada2, A. Nagahara1

Created: Thursday, 21 February 2019, 9:14 AM
P862: Dietary risk factors associated with onset of IBD: a systematic literature review and meta-analysis
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Mallon, K.(1)*;McBride , C.(2);Doherty , P.G.(3);Burns, D.R.(2);
Created: Friday, 14 July 2023, 11:12 AM
P863: Eradication of dysbiotic indigenous species by multiple antibiotic pre-treatment contribute to effective faecal microbiota transplantation
Year: 2018
Source: ECCO '18 Vienna
Authors:

D. Ishikawa1*, M. Takahashi1, S. Ito1, K. Okahara1, K. Haga1, M. Kamei1, O. Nomura1, T. Shibuya1, T. Osada2, A. Nagahara1

Created: Thursday, 21 February 2019, 9:14 AM
P863: Exploring patients' perceptions of clinical research in inflammatory bowel disease and barriers to participating in clinical trials
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Chatten, K.(1)*;Kalra, P.(2);Bower, P.(3);Mclaughlin, J.(4);Ghosh, S.(5);Limdi, J.(1);
Created: Friday, 14 July 2023, 11:12 AM